SVF (Stromal Vascular Fraction) therapy is becoming an increasingly recognized regenerative treatment approach for selected patients with Hip Avascular Necrosis (AVN) and Knee Osteoarthritis in India. Using regenerative cells obtained from a patient's own adipose (fat) tissue, SVF therapy is being incorporated into modern orthopedic care with a focus on joint preservation, improved function, and maintaining mobility. As regenerative medicine continues to advance, both patients and orthopedic specialists are showing growing interest in this biologically based treatment option.